A New Audio Interview with Dr. Stuart Titus, President and Chief Executive Officer of Medical Marijuana, Inc., is now at SmallCapVoice.com

Jonestown, Texas, UNITED STATES

AUSTIN, Texas, May 17, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) and SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with Medical Marijuana, Inc., a leading industrial hemp industry innovator, is now available. The interview can be heard at http://smallcapvoice.com/blog/5-16-16-smallcapvoice-interview-with-medical-marijuana-inc-mjna

Stuart W. Titus, PhD, President and CEO of Medical Marijuana, Inc. called in to SmallCapVoice.com to provide the listening audience with his personal insights into the Company’s recent news regarding how the Brazilian government has approved its hemp cannabidiol (CBD) oil product, Real Scientific Hemp Oil™ (RSHO™) from HempMeds Brasil™, for a fourth indication for import as a prescription medication for the treatment of cancer. In addition, Dr. Titus discussed that the Company's Real Scientific Hemp Oil-X™ (RSHO-X™) product is the first-ever cannabis product (high concentration natural botanical hemp-based cannabidiol (CBD) without THC) approved by federal authorities for import into Mexico, into what projects to be a "$10-12 billion" future cannabis market.

Dr. Titus states, “The U.S. is slowly moving forward with the legalization of medical cannabis and while we have great hopes for November's elections -- we see many Latin American countries moving forward in a swift manner toward the acceptance of non-psychoactive cannabinoids. Previously the acceptance of any cannabis-based product would have been unheard of in these nations -- but with our education combined with different systems of medical care, that is now rapidly changing. MJNA's brands RSHO and RSHO-X are welcome in two of Latin America's biggest countries and Puerto Rico has 12 registrations with our products. We look forward to reporting on further developments of this trend in the future.”

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://smallcapvoice.com/blog/smallcapvoice-about-our-small-cap-otc-investor-relations-company/

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

Medical Marijuana Inc. and HempMeds® do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

About Medical Marijuana Inc.
The mission of Medical Marijuana, Inc. (OTC Pink:MJNA) is to be the premier hemp industry innovator, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value.  For more information, please visit the company's website at: www.MedicalMarijuanaInc.com.

About HempMeds® Brasil™
HempMeds Brasil™ currently has four cannabis products approved for importation into Brazil as a prescription medication for Epilepsy, Parkinson's, Chronic Pain and Cancer. The company had the first-ever cannabis product allowed for import into Brazil and its products are currently subsidized by the Brazilian government, under their health care system, for all four medical indications listed above. HempMeds Brasil™ is working on additional approvals for multiple indications.

For further information, please contact:

Public Relations contact:

Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829-0070


Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)

Investor Relations:

Nicholas R. Massalas
Director of Business Development
Medical Marijuana Inc.
OTC Symbol: MJNA
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6505
Email: Nick@MedicalMarijuanainc.com

For SmallCapVoice.com 

Stuart T. Smith